Lorenzo Capussotti

Active 1990–2015

71
Papers
21,765
Citations
71
h-index
71
i10-index

Citations

Citations per year for Lorenzo Capussotti1939: 1 citations1986: 1 citations1991: 3 citations1992: 5 citations1993: 6 citations1994: 4 citations1995: 8 citations1996: 9 citations1997: 6 citations1998: 12 citations1999: 13 citations2000: 10 citations2001: 15 citations2002: 21 citations2003: 28 citations2004: 45 citations2005: 60 citations2006: 72 citations2007: 139 citations2008: 150 citations2009: 156 citations2010: 152 citations2011: 146 citations2012: 231 citations2013: 230 citations2014: 199 citations2015: 235 citations2016: 199 citations2017: 193 citations2018: 145 citations2019: 672 citations2020: 628 citations2021: 531 citations2022: 336 citations2023: 238 citations2024: 411 citations2025: 128 citations1940–1985: no citations, so these years are not shown1987–1990: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,478 citing papers, 20.6% of this breakdownItaly: 712 citing papers, 9.9% of this breakdownChina: 640 citing papers, 8.9% of this breakdownJapan: 485 citing papers, 6.8% of this breakdownFrance: 408 citing papers, 5.7% of this breakdownUnited Kingdom: 399 citing papers, 5.6% of this breakdownGermany: 355 citing papers, 4.9% of this breakdownNetherlands: 317 citing papers, 4.4% of this breakdownSpain: 227 citing papers, 3.2% of this breakdownCanada: 168 citing papers, 2.3% of this breakdownSwitzerland: 166 citing papers, 2.3% of this breakdownSouth Korea: 163 citing papers, 2.3% of this breakdown
0%20.6%Other 23.1%

Fields

  • Medicine92.3%
  • Biochemistry, Genetics and Molecular Biology5.3%
  • Immunology and Microbiology0.6%
  • Engineering0.6%
  • Computer Science0.3%
  • Pharmacology, Toxicology and Pharmaceutics0.2%
  • Other0.7%

Topics

  • Hepatocellular Carcinoma Treatment and Prognosis15.3%
  • Cholangiocarcinoma and Gallbladder Cancer Studies7.8%
  • Liver Disease Diagnosis and Treatment6.8%
  • Pancreatic and Hepatic Oncology Research6%
  • Colorectal Cancer Treatments and Studies4.7%
  • Gallbladder and Bile Duct Disorders4%
  • Other55.4%

Coauthors

All papers

Open in search
  1. Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Surgery 2011 cited by 2,273

  2. Bile leakage after hepatobiliary and pancreatic surgery: A definition and grading of severity by the International Study Group of Liver Surgery

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Surgery 2011 cited by 1,937

  3. A Molecularly Annotated Platform of Patient-Derived Xenografts (“Xenopatients”) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2011 cited by 953

  4. Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - HPB 2011 cited by 452

  5. Hepatic Insufficiency and Mortality in 1,059 Noncirrhotic Patients Undergoing Major Hepatectomy

    Authors: , , , , , , , , , , - Journal of the American College of Surgeons 2007 cited by 659

  6. A Snapshot of the Effective Indications and Results of Surgery for Hepatocellular Carcinoma in Tertiary Referral Centers

    Authors: , , , , , , , , , , , - Annals of Surgery 2013 cited by 489

  7. Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal Metastases

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2006 cited by 1,296

  8. A Clinical Outcome-Based Prospective Study on Venous Thromboembolism After Cancer Surgery

    Authors: , , , , , , , , , , , , - Annals of Surgery 2005 cited by 689

  9. Rates and Patterns of Recurrence Following Curative Intent Surgery for Colorectal Liver Metastasis

    Authors: , , , , , , , , , - Annals of Surgery 2009 cited by 791

  10. Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ⩽3cm. Results of a multicenter Italian survey

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2013 cited by 296

  11. Early Recurrence After Liver Resection for Colorectal Metastases: Risk Factors, Prognosis, and Treatment. A LiverMetSurvey-Based Study of 6,025 Patients

    Authors: , , , , , , , , , - Annals of Surgical Oncology 2013 cited by 263

  12. Effect of Surgical Margin Status on Survival and Site of Recurrence After Hepatic Resection for Colorectal Metastases

    Authors: , , , , , , , , , , , - Annals of Surgery 2005 cited by 1,098

  13. Surgical Management of Hepatic Neuroendocrine Tumor Metastasis: Results from an International Multi-Institutional Analysis

    Authors: , , , , , , , , , , , , , , , , , , , , - Annals of Surgical Oncology 2010 cited by 476

  14. Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis

    Authors: , , , , , , , , , , , , , , - Hepatology 2006 cited by 369

  15. Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma

    Authors: , , , , , , , , , , - Gastroenterology 2002 cited by 1,435

  16. Tumor Location Is a Strong Predictor of Tumor Progression and Survival in T2 Gallbladder Cancer

    Authors: , , , , , , , , , , , , , , - Annals of Surgery 2014 cited by 235

  17. Inhibition of MEK and PI3K/mTOR Suppresses Tumor Growth but Does Not Cause Tumor Regression in Patient-Derived Xenografts of RAS-Mutant Colorectal Carcinomas

    Authors: , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2012 cited by 194

  18. Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: A multicenter matched analysis with HCV-related HCC

    Authors: , , , , , , , , , , , , , , - Journal of Hepatology 2015 cited by 106

  19. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer

    Authors: , , , , , , , , , , , , , , , , , - British journal of surgery 2013 cited by 307

  20. Incidence of Finding Residual Disease for Incidental Gallbladder Carcinoma: Implications for Re-resection

    Authors: , , , , , , , , , , , - Journal of Gastrointestinal Surgery 2007 cited by 286

  21. Extended Preoperative Chemotherapy Does Not Improve Pathologic Response and Increases Postoperative Liver Insufficiency After Hepatic Resection for Colorectal Liver Metastases

    Authors: , , , , , , , , , , , , - Annals of Surgical Oncology 2010 cited by 276

  22. Postoperative Liver Dysfunction and Future Remnant Liver: Where Is the Limit?

    Authors: , , , , , , - World Journal of Surgery 2007 cited by 229

  23. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma

    Authors: , , , , , , , , , , , , , , , , , - Cancer 2012 cited by 212

  24. Somatic Mutations of Epidermal Growth Factor Receptor in Bile Duct and Gallbladder Carcinoma

    Authors: , , , , , , , , , - Clinical Cancer Research 2006 cited by 170